Approval to consider report of the postapproval studies a final report and to discontinue all PRK postapproval study requirements.  The Model C(STAR) device, as modified in supplement 7, will be marketed under the trade name VISX STAR S2 Excimer Laser System and is indicated for the treatment of myopia, astigmatism and hyperopia (sphere only).